Showing results (91-100 of 281) with videos related to

Sort By:
Pageof 29
Research in Social & Administrative Pharmacy : RSAP|December 4, 2020
Racial/ethnic disparities in measure calculations for Part D Star Ratings among Medicare beneficiaries with diabetes, hypertension, and/or hyperlipidemiaChi Chun Steve Tsang, Jim Y Wan, Marie A Chisholm-Burns, et al.
Kidney International|September 18, 2014
Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetesVasilios Papademetriou, Laura Lovato, Michael Doumas, et al.
Annals of Internal Medicine|September 13, 2013
Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort studyCsaba P Kovesdy, Anthony J Bleyer, Miklos Z Molnar, et al.
Hypertension (Dallas, Tex. : 1979)|June 8, 2023
Single-Pill Combination Product Availability of the Antihypertensive Regimens Used for Intensive Systolic Blood Pressure Treatment in the Systolic Blood Pressure Intervention TrialJordan B King, Catherine G Derington, Jennifer S Herrick, et al.
Journal of Managed Care & Specialty Pharmacy|February 1, 2018
Racial and Ethnic Disparities in Meeting MTM Eligibility Criteria Based on Star Ratings Compared with the Medicare Modernization ActChristina A Spivey, Junling Wang, Yanru Qiao, et al.
Hypertension (Dallas, Tex. : 1979)|February 18, 2009
Antihypertensive prescriptions for newly treated patients before and after the main antihypertensive and lipid-lowering treatment to prevent heart attack trial results and seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure guidelinesPaul Muntner, Marie Krousel-Wood, Amanda D Hyre, et al.
The American Journal of Geriatric Cardiology|January 5, 2008
Efficacy and safety of fixed combinations of irbesartan/hydrochlorothiazide in older vs younger patients with hypertension uncontrolled with monotherapyWilliam C Cushman, Joel M Neutel, Elijah Saunders, et al.
Journal of Pharmaceutical Health Services Research : an Official Journal of the Royal Pharmaceutical Society of Great Britain|March 26, 2019
Predictive Value Positive of MTM Eligibility Criteria under MMA and ACA in Identifying Individuals with Medication Utilization IssuesYanru Qiao, Christina A Spivey, Junling Wang, et al.
American Journal of Hypertension|January 24, 2018
The Effects of eGFR Change on CVD, Renal, and Mortality Outcomes in a Hypertensive Cohort Treated With 3 Different Antihypertensive MedicationsJoshua I Barzilay, Barry R Davis, Sara L Pressel, et al.
JAMA Network Open|September 1, 2023
A Centralized EHR-Based Model for the Recruitment of Rural and Lower Socioeconomic Participants in Pragmatic Trials: A Secondary Analysis of the Diuretic Comparison ProjectCynthia Hau, Jimmy T Efird, Sarah M Leatherman, et al.
Pageof 29